Company Analysis

United Therapeutics Corporation (UTHR)

Nasdaq: UTHR · Pharmaceutical Preparations · Silver Spring, MD · filing with the SEC since 1999
Grade7.3
◀ Past 7.7● Present 7.9▶ Future 6.1

Who runs United Therapeutics Corporation

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Rothblatt Martine A
Chairperson & CEO. First filing Jan 2006, latest Nov 12, 2026, 501 filings in all.
Officers reporting now
4
of 16 people with a filing in the last fifteen months
Directors reporting now
12
20 people on the record since 2006
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Rothblatt Martine AChairperson & CEOJan 2006Nov 12, 20262,176 · $972M
Mahon Paul AEVP & GENERAL COUNSELJan 2006Nov 5, 2026203 · $114M
Edgemond JamesCFO AND TREASURERMar 2015Jun 23, 2026365 · $193M
Benkowitz MichaelPRESIDENT AND COOJun 2016May 14, 2026125 · $159M
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Patusky ChristopherdirectorJul 2006Nov 10, 20264 · $3.4M
Mesa NildadirectorNov 2018Sep 15, 20264 · $400,000
Causey ChristopherdirectorMar 2006Jul 23, 20265 · $2.3M
Dzau Victor JdirectorJul 2026Jul 23, 2026none
Giltner RicharddirectorMay 2009Jul 23, 2026none
Kurzweil RaydirectorFeb 2006Jul 23, 20261 · $2.4M
Malcolm JandirectorJun 2024Jul 23, 20269 · $400,000
Maxwell LindadirectorSep 2020Jul 23, 2026none
Olian Judy D.directorJun 2015Jul 23, 20264 · $400,000
Sullivan Louis WdirectorJul 2006Jul 23, 20262 · $3.0M
Thompson Tommy GdirectorJan 2010Jul 23, 20265 · $2.5M
Tracey KevindirectorJan 2026Jul 23, 2026none
Earlier names on the record4, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton UTHR · research, not advice